Magnetic resonance imaging tracking of graft survival in the infarcted heart: Iron oxide particles versus ferritin overexpression approach

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 19, Issue 4, 2014, Pages 358-367

  Naumova, Anna V ^a,b   Balu, Niranjan ^a,b   Yarnykh, Vasily L ^a,b   Reinecke, Hans ^b   Murry, Charles E ^b,c   Yuan, Chun ^a,b,c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c University of Washington   (United States)

Author keywords

Acute myocardial infarction; Cell transplantation; Ferritin; Gene reporter; Iron oxide nanoparticles; Magnetic resonance imaging

Indexed keywords

FERRITIN; IRON OXIDE; NANOPARTICLE;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LABELING; CELL SURVIVAL; CELL TRANSPLANTATION; CELL VIABILITY; CONTROLLED STUDY; GENE OVEREXPRESSION; GRAFT SURVIVAL; HEART LEFT VENTRICLE; MOUSE; MYOBLAST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 84904737596     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248414525999     Document Type: Article

References (53)

1. Su W, Leng L, Han Z, He Z, Li Z. Bioluminescence imaging of human embryonic stem cell-derived endothelial cells for treatment of myocardial infarction. Methods Mol Biol. 2013;1052: 1-13.
2. Paulis LE, Klein AM, Ghanem A, et al. Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves longterm survival. PLoS One. 2013;8(4):e61510.
3. Aswendt M, Adamczak J, Couillard-Despres S, Hoehn M. Boosting bioluminescence neuroimaging: an optimized protocol for brain studies. PLoS One. 2013;8(2):e55662.
4. Terrovitis J, Lautamäki R, Bonios M, et al. Noninvasive quantification and optimization of acute cell retention by in vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery. J Am Coll Cardiol. 2009;54(17):1619-1626.
5. Bonios M, Chang CY, Pinheiro A, et al. Cardiac resynchronization by cardiosphere-derived stem cell transplantation in an experimental model of myocardial infarction. J Am Soc Echocardiogr. 2011;24(7):808-814.
6. Arbab AS, Thiffault C, Navia B, et al. Tracking of In-111-labeled human umbilical tissue-derived cells (hUTC) in a rat model of cerebral ischemia using SPECT imaging. BMC Med Imaging. 2012;12:33.
7. Templin C, Zweigerdt R, Schwanke K, et al. Transplantation and tracking of human-induced pluripotent stem cells in a pig model of myocardial infarction: assessment of cell survival, engraftment, and distribution by hybrid single photon emission computed tomography/computed tomography of sodium iodide symporter transgene expression. Circulation. 2012;126(4):430-439.
8. Shapiro EM, Skrtic S, Sharer K, Hill JM, Dunbar CE, Koretsky AP. MRI detection of single particles for cellular imaging. Proc Natl Acad Sci U S A. 2004;101(30):10901-10906. (Pubitemid 38989558)
9. Hinds KA, Hill JM, Shapiro EM, et al. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood. 2003; 102(3):867-872. (Pubitemid 36917777)
10. Kraitchman DL, Heldman AW, Atalar E, et al. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003;107(18):2290-2293. (Pubitemid 36578497)
11. Ebert SN, Taylor DG, Nguyen HL, et al. Noninvasive tracking of cardiac embryonic stem cells in vivo using magnetic resonance imaging techniques. Stem Cells. 2007;25(11):2936-2944. (Pubitemid 350127879)
12. Bulte JW, Arbab AS, Douglas T, Frank JA. Preparation of magnetically labeled cells for cell tracking by magnetic resonance imaging. Methods Enzymol. 2004;386:275-299. (Pubitemid 38657598)
13. Frank JA, Miller BR, Arbab AS, et al. Clinically applicable labeling of mammalian and stem cells by combining superparamagnetic iron oxides and transfection agents. Radiology. 2003; 228(2):480-487. (Pubitemid 36910091)
14. Bulte JW, Kraitchman DL. Monitoring cell therapy using iron oxide MR contrast agents. Curr Pharm Biotechnol. 2004;5(6): 567-584. (Pubitemid 39654853)
15. Zhou R, Idiyatullin D, Moeller S, et al. SWIFT detection of SPIOlabeled stem cells grafted in the myocardium. Magn Reson Med. 2010;63(5):1154-1161.
16. Yang Y, Dreessen de Gervai P, Sun J, Glogowski M, Gussakovsky E, Kupriyanov V. MRI studies of cryoinjury infarction in pig hearts: ii. Effects of intrapericardial delivery of adiposederived stem cells (ADSC) embedded in agarose gel. NMR Biomed. 2012;25(2):227-235.
17. Cohen B, Dafni H, Meir G, Harmelin A, Neeman M. Ferritin as an endogenous MRI reporter for noninvasive imaging of gene expression in C6 glioma tumors. Neoplasia. 2005;7(2):109-117. (Pubitemid 40315988)
18. Genove G, DeMarco U, Xu H, Goins WF, Ahrens ET. A new transgene reporter for in vivo magnetic resonance imaging. Nat Med. 2005;11(4):450-454. (Pubitemid 40562338)
19. Harrison PM, Arosio P. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta. 1996;1275(3):161-203. (Pubitemid 26248989)
20. Treffry A, Zhao Z, QuailMA, Guest JR, Harrison PM. Dinuclear center of ferritin: studies of iron binding and oxidation show differences in the two iron sites. Biochemistry. 1997;36(2): 432-441. (Pubitemid 27043479)
21. Cozzi A, Corsi B, Levi S, Santambrogio P, Albertini A, Arosio P. Overexpression of wild type and mutated human ferritin H-chain in HeLa cells: in vivo role of ferritin ferroxidase activity. J Biol Chem. 2000;275(33):25122- 25129.
22. Corsi B, Cozzi A, Arosio P, et al. Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism. J Biol Chem. 2002;277(25):22430-22437. (Pubitemid 34967214)
23. Vymazal J, Brooks RA, Bulte JW, Gordon D, Aisen P. Iron uptake by ferritin: NMR relaxometry studies at low iron loads. J Inorg Biochem. 1998;71(3-4):153-157. (Pubitemid 28531534)
24. Herynek V, Bulte JW, Douglas T, Brooks RA. Dynamic relaxometry: application to iron uptake by ferritin. J Biol Inorg Chem. 2000;5(1):51-56. (Pubitemid 30120587)
25. Feng Y, Liu Q, Zhu J, Xie F, Li L. Efficiency of ferritin as anMRI reporter gene in NPC cells is enhanced by iron supplementation. J Biomed Biotechnol. 2012;2012:434878.
26. Aung W, Hasegawa S, Koshikawa-Yano M, et al. Visualization of in vivo electroporation-mediated transgene expression in experimental tumors by optical and magnetic resonance imaging. Gene Ther. 2009;16(7):830-839.
27. Liu J, Cheng EC, Long RC, et al. Noninvasive monitoring of embryonic stem cells in vivo with MRI transgene reporter. Tissue Eng Part C Methods. 2009;15(4):739-747.
28. Ono K, Fuma K, Tabata K, Sawada M. Ferritin reporter used for gene expression imaging by magnetic resonance. Biochem Biophys Res Commun. 2009;388(3):589-594.
29. Kim HS, Cho HR, Choi SH, Woo JS, Moon WK. In vivo imaging of tumor transduced with bimodal lentiviral vector encoding human ferritin and green fluorescent protein on a 1.5 T clinical magnetic resonance scanner. Cancer Res. 2010;70(18):7315-7324.
30. Vande Velde G, Raman Rangarajan J, Vreys R, et al. Quantitative evaluation of MRI-based tracking of ferritin-labeled endogenous neural stem cell progeny in rodent brain. Neuroimage. 2012; 62(1):367-380.
31. Iordanova B, Ahrens ET. In vivo magnetic resonance imaging of ferritin-based reporter visualizes native neuroblast migration. Neuroimage. 2012;59(2):1004-1012.
32. Campan M, Lionetti V, Aquaro GD, et al. Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. Am J Physiol Heart Circ Physiol. 2011;300(6):H2238-H2250.
33. Terashima M, Uchida M, Kosuge H, et al. Human ferritin cages for imaging vascular macrophages. Biomaterials. 2011;32(5): 1430-1437.
34. Uchida M, Terashima M, Cunningham CH, et al. A human ferritin iron oxide nano-composite magnetic resonance contrast agent. Magn Reson Med. 2008;60(5):1073-1081.
35. Cohen B, Ziv K, Plaks V, et al. MRI detection of transcriptional regulation of gene expression in transgenic mice. Nat Med. 2007;13(4):498-503. (Pubitemid 46559823)
36. Deutsch U, Schlaeger TM, Dehouck B, et al. Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice. Exp Cell Res. 2008;314(6):1202-1216.
37. Ziv K, Meir G, Harmelin A, Shimoni E, Klein E, Neeman M. Ferritin as a reporter gene for MRI: chronic liver over expression of H-ferritin during dietary iron supplementation and aging. NMR Biomed. 2010;23(5):523-531.
38. Li K, Zhang ZP, Luo M, et al. Multifunctional ferritin cage nanostructures for fluorescence and MR imaging of tumor cells. Nanoscale. 2012;4(1):188-193.
39. Kramer RM, Li C, Carter DC, Stone MO, Naik RR. Engineered protein cages for nanomaterial synthesis. J Am Chem Soc. 2004; 126(41):13282-13286. (Pubitemid 39382754)
40. Uchida M, Flenniken ML, Allen M, et al. Targeting of cancer cells with ferrimagnetic ferritin cage nanoparticles. J Am Chem Soc. 2006;128(51):16626- 16633. (Pubitemid 46032741)
41. Naumova AV, Reinecke H, Yarnykh V, Deem J, Yuan C, Murry CE. Ferritin overexpression for noninvasive magnetic resonance imaging-based tracking of stem cells transplanted into the heart. Mol Imaging. 2010;9(4):201-210.
42. Naumova AV, Yarnykh VL, Balu N, Reinecke H, Murry CE, Yuan C. Quantification of MRI signal of transgenic grafts overexpressing ferritin in murine myocardial infarcts. NMR Biomed. 2012;25(10):1187-1195.
43. Sekine H, Shimizu T, Dobashi I, et al. Cardiac cell sheet transplantation improves damaged heart function via superior cell survival in comparison with dissociated cell injection. Tissue Eng Part A. 2011;17(23-24):2973-2980.
44. Amsalem Y, Mardor Y, Feinberg MS, et al. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation. 2007;116 (11 suppl): I38-I45. (Pubitemid 47480768)
45. Roell W, Lewalter T, Sasse P, et al. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia. Nature. 2007;450:819-824. (Pubitemid 350237591)
46. van der Bogt KE, Sheikh AY, Schrepfer S, et al. Comparison of different adult stem cell types for treatment of myocardial ischemia. Circulation. 2008;118:S121-S129.
47. van derBogtKE, Schrepfer S, YuJ, et al.Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart. Transplantation. 2009;87(5):642-652.
48. Robey TE, Saiget MK, Reinecke H, Murry CE. Systems approaches to preventing transplanted cell death in cardiac repair. J Mol Cell Cardiol. 2008;45(4):567-581.
49. Murry CE, Whitney ML, Reinecke H. Muscle cell grafting for the treatment and prevention of heart failure. J Card Fail. 2002; 8(6 suppl):S532-S541. (Pubitemid 36083109)
50. Silberstein L, Webster SG, Travis M, Blau HM. Developmental progression of myosin gene expression in cultured muscle cells. Cell. 1986;46(7):1075-1081. (Pubitemid 17182731)
51. Levi S, Luzzago A, Cesareni G, et al. Mechanism of ferritin iron uptake: activity of the H-chain and deletion mapping of the ferrooxidase site. A study of iron uptake and ferro-oxidase activity of human liver, recombinant H-chain ferritins, and of two H-chain deletion mutants. J Biol Chem. 1988;263(34):18086-18092. (Pubitemid 19005083)
52. Lawson DM, Treffry A, Artymiuk PJ, et al. Identification of the ferroxidase centre in ferritin. FEBS Lett. 1989;254(1-2):207-210. (Pubitemid 19217880)
53. Terrovitis J, Stuber M, Youssef A, et al. Magnetic resonance imaging overestimates ferumoxide-labeled stem cell survival after transplantation in the heart. Circulation. 2008;117(12):1555-1562. (Pubitemid 351444664)